日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AMKL chimeric transcription factors are potent inducers of leukemia

AMKL嵌合转录因子是白血病的强效诱导剂。

Dang, J; Nance, S; Ma, J; Cheng, J; Walsh, M P; Vogel, P; Easton, J; Song, G; Rusch, M; Gedman, A L; Koss, C; Downing, J R; Gruber, T A

Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy

微小残留病灶对接受反应适应性治疗的不同亚型急性淋巴细胞白血病患儿的临床影响

Pui, C-H; Pei, D; Raimondi, S C; Coustan-Smith, E; Jeha, S; Cheng, C; Bowman, W P; Sandlund, J T; Ribeiro, R C; Rubnitz, J E; Inaba, H; Gruber, T A; Leung, W H; Yang, J J; Downing, J R; Evans, W E; Relling, M V; Campana, D

A revised definition for cure of childhood acute lymphoblastic leukemia

儿童急性淋巴细胞白血病治愈的修订定义

Pui, C H; Pei, D; Campana, D; Cheng, C; Sandlund, J T; Bowman, W P; Hudson, M M; Ribeiro, R C; Raimondi, S C; Jeha, S; Howard, S C; Bhojwani, D; Inaba, H; Rubnitz, J E; Metzger, M L; Gruber, T A; Coustan-Smith, E; Downing, J R; Leung, W H; Relling, M V; Evans, W E

Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study

FKBP5基因变异对儿童急性髓系白血病患者临床反应的影响:一项初步研究

Mitra, A K; Crews, K; Pounds, S; Cao, X; Downing, J R; Raimondi, S; Campana, D; Ribeiro, R C; Rubnitz, J E; Lamba, J K

IDH1 and IDH2 mutations in pediatric acute leukemia.

儿童急性白血病中的 IDH1 和 IDH2 突变

Andersson A K, Miller D W, Lynch J A, Lemoff A S, Cai Z, Pounds S B, Radtke I, Yan B, Schuetz J D, Rubnitz J E, Ribeiro R C, Raimondi S C, Zhang J, Mullighan C G, Shurtleff S A, Schulman B A, Downing J R

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study

CD33编码多态性与儿童急性髓系白血病患者对吉妥珠单抗奥佐米星的反应:一项初步研究

Lamba, J K; Pounds, S; Cao, X; Downing, J R; Campana, D; Ribeiro, R C; Pui, C-H; Rubnitz, J E

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1

t(1;19)/TCF3-PBX1 前 B 细胞白血病中枢神经系统复发风险增加

Jeha, S; Pei, D; Raimondi, S C; Onciu, M; Campana, D; Cheng, C; Sandlund, J T; Ribeiro, R C; Rubnitz, J E; Howard, S C; Downing, J R; Evans, W E; Relling, M V; Pui, C-H

The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1

E2A-HLF癌蛋白激活Groucho相关基因并抑制Runx1。

Dang, J; Inukai, T; Kurosawa, H; Goi, K; Inaba, T; Lenny, N T; Downing, J R; Stifani, S; Look, A T

Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein

TEL 和 AML-1 都为 t(12;21) 融合蛋白贡献了抑制结构域。

Fenrick, R; Amann, J M; Lutterbach, B; Wang, L; Westendorf, J J; Downing, J R; Hiebert, S W

The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription

t(12;21)易位使AML-1B从转录激活因子转变为转录抑制因子。

Hiebert, S W; Sun, W; Davis, J N; Golub, T; Shurtleff, S; Buijs, A; Downing, J R; Grosveld, G; Roussell, M F; Gilliland, D G; Lenny, N; Meyers, S